Earnings360 Newsletter for 9/25/2024

Earnings360 Newsletter for 9/25/2024
Micron Technology, Cintas, AutoZone & more: Earnings results, news and what's next. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­
Earnings360 Home
3 tickers just showed unusual early patterns. See the Trading Ideas report now. (ad)
Quiet shifts in volume and structure are forming. Grab the Trading Ideas signal guide.
Spot the Signals Before They Become Obvious

We track early shifts in volume, structure, and emerging trends as they begin to form.

Trading Ideas focuses on data patterns that often develop before broader visibility.
 
Join Free — Get Your Free Trading Ideas Report Instantlytc pixel
Top Earnings News
Don’t Overlook Mosaic’s Challenges—They Might Spark Opportunity
3 Beaten Up Experiential Stocks to Cash in on a Good Time
U.S. Army Taps Nasdaq Firm for Rare Earth Processingtc pixel 

Wednesday, September 25 Today's Earnings Announcements

CompanyCurrent PriceConsensus EPSActual EPSBeat/MissConsensus RevenueActual RevenueYoY Revenue GrowthReport
CNXC Concentrix$28.22$2.93$2.87($0.06)$2.38 billion$2.39 billion46.2%→
CTAS Cintas$212.30$1.00$1.10$0.10$2.49 billion$2.50 billion6.8%→
FUL H. B. Fuller$51.02$1.23$1.13($0.10)$944.04 million$917.93 million1.9%→
JEF Jefferies Financial Group$43.58$0.78$0.75($0.03)$1.71 billion$1.68 billion42.4%→
MU Micron Technology$904.90$0.97$1.18$0.21$7.65 billion$7.75 billion93.3%→
WS Worthington Steel$41.56$0.55$0.56$0.01$748.40 million$834 million-7.9%→
This biotech’s early trial data shows 63% cancer reduction (ad)
Microscopic footage reveals immune cells destroying cancer cells
Time-lapse footage from a recent clinical study shows Natural Killer cells attacking and eliminating cancer cells - and early human data revealed up to a 63.7 percent reduction in cancer burden.

One NASDAQ-listed biotech's TriKE platform is designed to keep these immune cells locked onto tumors longer. Its next-generation version, showing potential for 10 to 40 times greater potency, has just cleared an important FDA milestone.
 
Watch the microscopic footage and learn about the next catalysttc pixel

Tuesday, September 24 Yesterday's Earnings Announcements

CompanyCurrent PriceConsensus EPSActual EPSBeat/MissConsensus RevenueActual RevenueYoY Revenue GrowthReport
AZO AutoZone$3,099.85$53.31$48.11($5.20)$6.25 billion$6.21 billion9.0%→
KBH KB Home$42.55$2.06$2.04($0.02)$1.73 billion$1.75 billion10.3%→
PRGS Progress Software$42.25$1.14$1.26$0.12$176.16 million$178.69 million1.7%→
THO Thor Industries$65.86$1.35$1.68$0.33$2.47 billion$2.53 billion-7.4%→
WOR Worthington Enterprises$63.41$0.71$0.50($0.21)$296.05 million$257.31 million-17.5%→

MarketBeat Earnings Tools

Get Earnings Reports, Analysts' Forecasts, and Conference Call Transcripts.